Alzheimer’s disease therapy navigating barriers using a nanochip
The blood–brain barrier (BBB) has posed a challenge to drug delivery in the medical field, especially in treatment of neurological disorders such as Alzheimer’s disease, for many years now. Nanomedicine has been at the heart of research into how to overcome the hurdles presented by the BBB and researchers from Technion-Israel Institute of Technology (Haifa, Israel) and Bar-Ilan University (Tel Aviv, Israel) have found a promising strategy. The researchers have inserted a nanochip inside the skull, just outside of the brain (on the dura mater). The chip can then deliver the therapeutic that is needed. For the purpose of their...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
